ReviewTranscription2025

Aryl hydrocarbon receptor as a drug target in advanced prostate cancer therapy - obstacles and perspectives.

Jiřina Procházková et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.